Diversity of IgG autoantibodies of 4 Chinese intravenous immunoglobulins
Zhongguo shuxue zazhi, 2023 Objective To develop methods to display the IgG autoantibody repertoire of intravenous immunoglobulin (IVIG) products, analyze the different types of antibodies and study the diversity of IgG autoantibody in 4 IVIG preparations from different Chinese ...
Xiaochen YAN +6 more
doaj +1 more source
Detection of antibodies to Sendai virus by enzyme-linked immunosorbent assay (ELISA) [PDF]
, 1979 An enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to Sendai virus, a paramyxovirus, is described. The assay was found to be about 20-fold more sensitive than the hemagglutination inhibition assay.
Avrameas +17 more
core +1 more source
Human parvovirus B19 and blood product safety. A tale of twenty years of improvements [PDF]
, 2015 Parvovirus B19 (B19V), long known to be the causative agent of erythema infectiosum (fifth disease), is not a newly emerging agent. The aim of this review is to analyse the role played by this virus in compromising safety in transfusion medicine and the ...
Calizzani, Gabriele +7 more
core +1 more source
SPECIFIC IMMUNOGLOBULINS FOR INTRAVENOUS INJECTION IN PEDIATRIC PRACTICES
Педиатрическая фармакология, 2007 The article presents information on the protective and therapeutic efficiency of specific immunoglobulins for intravenous injection. The author gives a characteristics and provides regimes of medication dosage of specific immunoglobulins for intravenous ...
A.L. Zaplatnikov
doaj +2 more sources
Successful treatment of pyoderma gangrenosum with Janus kinase 1/2 inhibition
JEADV Clinical Practice, 2022 Pyoderma gangrenosum (PG) is a rare, autoinflammatory disease leading to painful, hard‐to‐treat ulcers. Besides systemic glucocorticoids, a plethora of classic immunosuppressants, biologics and small molecules have been reported to improve PG disease ...
Sebastian Sitaru +2 more
doaj +1 more source
Nephrotoxicity of intravenous immunoglobulin [PDF]
QJM, 2000 Individual case reports have documented nephrotoxicity of intravenous immunoglobulin (IVIG) preparations, but the true incidence of renal dysfunction is unknown and many data sheets do not include renal impairment as a side-effect of these preparations.
J B, Levy, C D, Pusey
openaire +2 more sources
HAEMAGGLUTINATION TECHNIQUES TO EVALUATE SPECIFIC SAFETY OF HUMAN INTRAVENOUS IMMUNOGLOBULINS
Медицинская иммунология, 2017 The safety issues of human intravenous immunoglobulin preparations are particularly important in modern pharmacotherapy for immunodeficiencies, hematologic and neurologic diseases, like as at transplant centers. Upon massive infusions of these media some
O. G. Kornilova +5 more
doaj +1 more source
Intravenous Immunoglobulin Induced Transaminitis
Cureus, 2023 Intravenous immunoglobulin (IVIG) is a common therapeutic modality used in immune-mediated neuropathy. While the therapeutic benefits are well known, adverse reactions have been reported. One such adverse event, though rare, is transaminitis, which appears to be a transient and a self-limiting adverse reaction.
Vijaya Prakash, Aviraag +3 more
openaire +2 more sources
Eosinophilic meningoencephalitis successfully treated with glucocorticoids and intravenous immunoglobulin: a case report [PDF]
EncephalitisEosinophilic meningoencephalitis is a rare inflammatory condition of the central nervous system. As a limited number of cases has been reported, debate remains on the optimal treatment.
Soo Hyun Ahn +4 more
doaj +1 more source
IVIg treatment reduces catalytic antibody titers of renal transplanted patients. [PDF]
PLoS ONE, 2013 Catalytic antibodies are immunoglobulins endowed with enzymatic activity. Catalytic IgG has been reported in several human autoimmune and inflammatory diseases.
Ankit Mahendra +12 more
doaj +1 more source